Context Capital Management, LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$1
-100.0%
57,5260.0%0.00%–
Q3 2022$5,0000.0%57,5260.0%0.00%–
Q2 2022$5,000
-58.3%
57,5260.0%0.00%
-100.0%
Q1 2022$12,000–57,526–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders